ImmunityBio's Anktiva wins conditional EMA approval, but faces stiff competition and financial risks. Click for why IBRX ...

Such an advancement would allow for one of the most successful non-chemo cancer treatments to be done both faster and cheaper ...

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

Can the weakened immune systems of older individuals be rejuvenated? Researchers from the German Cancer Research Center (DKFZ ...

In students with trouble sleeping, there was also a link between higher anxiety and lower NK cell levels. This means that ...

The CancerVax platform is designed to harness the body’s existing immunity to detect, mark, and kill cancer cells with ...

Researchers are striving to understand the impact a phenomenon known as original antigenic sin has on immunity to the virus.

Lehigh Valley Health Network, part of Jefferson Health, dedicated the Peter and Odete Kelly Center for Personalized Cancer Immunotherapy in a celebratory event at Lehigh Valley Hospital–Cedar Crest. A ...

Two recent studies show the novel therapy works in people with multiple myeloma, but researchers are trying to minimize side ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

A hidden “jack-in-the-box” mechanism inside T cells may hold the key to unlocking more powerful cancer immunotherapies.